Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoposide + Cisplatin vs Temozolomide in MGMT Unmethylated Glioblastoma
NCT05694416Phase 2Unknown
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Feb 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of etoposide, cisplatin in glioblastoma (GBM), sponsored by Zhongnan Hospital of Wuhan University. Status: unknown.
02
Drugs
etoposidecisplatin
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT05694416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05694416.